Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
120 participants
INTERVENTIONAL
2018-01-04
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia
NCT01394471
Target Engagement for Oxytocin: Dose Ranging Study
NCT02498236
Adult Study Oxytocin - Behavioral
NCT02567032
Adult Oxytocin Study
NCT02577575
Pharmacological Approach to Improve the Outcome of Social Cognition Training
NCT01517360
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxytocin with SCST
Oxytocin with SCST (active condition)
Oxytocin nasal spray
nasal spray
Social Cognition Skills Training
Group based training in social cognition skills
Oxytocin with Health Management
Administration of OT with control psychosocial treatment
Oxytocin nasal spray
nasal spray
Health Management
Group-based training in mental health management
Placebo with SCST
Administration of Placebo with active psychosocial treatment
Social Cognition Skills Training
Group based training in social cognition skills
Placebo nasal spray
placebo condition
Placebo with HM
Administration of Placebo with control psychosocial treatment
Health Management
Group-based training in mental health management
Placebo nasal spray
placebo condition
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxytocin nasal spray
nasal spray
Social Cognition Skills Training
Group based training in social cognition skills
Health Management
Group-based training in mental health management
Placebo nasal spray
placebo condition
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* stable on an antipsychotic medication
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephen R. Marder
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen Marder, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCLA
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OT R33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.